China is the country with the highest number of diabetics worldwide, with around *** million people suffering from the disease. By the year 2050, it is predicted that China will have around *** million people with diabetes. Death from diabetes Diabetes is one of the leading causes of death worldwide, accounting for **** million deaths in 2021. Diabetes at least doubles one’s chance of dying prematurely, and many places in the world lack appropriate treatment options. The highest number of deaths from diabetes comes from the Western Pacific, where around *** million people died from the disease in 2024. Obesity One of the biggest risk factors for developing diabetes is being overweight or obese. Rates of obesity have increased in recent years in many countries around the world. In the United States, for example, it is estimated that around ** percent of the adult population was obese in 2023, compared to ** percent of the population in 2011.

In 2024, Pakistan had the highest prevalence of diabetes worldwide, with around ** percent of the population suffering from the disease. Diabetes mellitus, or simply, diabetes, refers to a group of metabolic disorders that cause high blood sugar levels. Diabetes can be prevented and treated though exercise, maintaining normal body weight, and healthy eating, but is usually managed with insulin injections. Costs As of 2024, there were almost *** million people worldwide who had diabetes. With such a huge number of people suffering from this disease, it is no surprise that spending on diabetes can be very high. It is estimated that the United States alone spent around ***** billion U.S. dollars on diabetes health expenditure in 2024. The countries with the highest spending per patient with diabetes include Switzerland, the United States, and Norway. Death Diabetes is among the leading ten causes of death worldwide, accounting for around **** million deaths in 2021. Complications resulting from diabetes include chronic kidney disease, stroke, and cardiovascular disease. The risk of early death is at least doubled among those with diabetes. The Western Pacific reports the highest number of deaths from diabetes, followed by North America and the Caribbean.

In 2024, around 16 percent of adults between the ages of 20 and 79 had diabetes in Turkey. Other selected countries with a high prevalence of diabetes that year included Mexico, the United States, and Portugal. Diabetes is a metabolic disease that causes high blood sugar levels. Diabetes worldwide In 2024, an estimated 11 percent of the global adult population had diabetes. In concrete numbers, there were about 589 million diabetic adults (20-79 years) worldwide in 2024, and this total is predicted to grow to approximately 852.5 million by the year 2050. Spending per patient The country that spent the most on patients with diabetes in 2024 was Switzerland. At that time, providing for a diabetic patient in Switzerland cost an average of over 12 thousand U.S. dollars. The United States stood in second place, spending about 10,500 U.S. dollars per patient. In the same year, the ten countries by lowest average spending per person with diabetes were all African and Asian countries. Bangladesh had the lowest annual diabetes-related health expenditures per person, with just 74 U.S. dollars.

The average for 2021 based on 11 countries was 9.58 percent. The highest value was in Malaysia: 19 percent and the lowest value was in Vietnam: 6.1 percent. The indicator is available from 2000 to 2021. Below is a chart for all countries where data are available.

In 2024, more than ** percent of the population aged 20 to 79 years in Pakistan had diabetes. In comparison, Timor-Leste had the lowest prevalence of diabetic people aged 20 to 79 across the Asia-Pacific region that year, approximately *** percent.

Portugal had the highest prevalence of diabetes in Europe among their adult population with **** percent living with diabetes, as of 2024, Croatia followed with the second-highest share at **** percent. Conversely, Ireland was the country with the lowest prevalence of diabetes in Europe at *** percent. Diabetes-related deaths The highest number of diabetes-related deaths in Europe, at almost ******, was recorded in Germany in 2024. Italy and France followed, with roughly *******and ****** deaths, respectively. Diabetes risk factors in Europe One of the major contributing factors to type 2 diabetes is being overweight or obese. As of 2022, Greece had the highest share of overweight population across Europe, with *****percent. The lack of sports and exercise is also another risk factor. As of 2022, Portugal was the European country with the highest share of people never exercising or engaging in sports, with ** percent.

In 2024, India had the highest number of children and adolescents aged under 20 who were living with type 1 diabetes, with around 301,000 cases. At that time, an estimated 197,000 children and adolescents in the United States had type 1 diabetes. This statistic shows the countries with the highest number of children and adolescents aged 0 to 19 years with type 1 diabetes in 2024.

Global Diabetes Prevalence by Country, 2021 Discover more data with ReportLinker!

Global Diabetes Mellitus Mortality by Country, 2023 Discover more data with ReportLinker!

Global Hospital Discharges for Diabetes Cases by Country, 2023 Discover more data with ReportLinker!

Global Potential Years of Life Lost from Diabetes Mellitus by Country, 2023 Discover more data with ReportLinker!

This statistic shows the top 10 countries based on number of new cases of type 1 diabetes per 100,000 children aged 0 to 14 years, in 2021. Finland had the highest rate with 52.2 new cases per 100,000 children per year.

Global Diabetes Medicine Use by Country, 2023 Discover more data with ReportLinker!

This dataset about Diabetes by Country is extracted from Flourish visualisation. If you want to know more about Flourish click here.

This chart shows the rate of hospitalizations for short- term complications of diabetes for the most recent data year by age range and county. It also shows the 2017 objective by age range. This chart is based on one of three datasets related to the Prevention Agenda Tracking Indicators county level data posted on this site. Each dataset consists of county level data for 68 health tracking indicators and sub-indicators for the Prevention Agenda 2013-2017: New York State’s Health Improvement Plan. A health tracking indicator is a metric through which progress on a certain area of health improvement can be assessed. The indicators are organized by the Priority Area of the Prevention Agenda as well as the Focus Area under each Priority Area. Each dataset includes tracking indicators for the five Priority Areas of the Prevention Agenda 2013-2017. The most recent year dataset includes the most recent county level data for all indicators. The trend dataset includes the most recent county level data and historical data, where available. Each dataset also includes the Prevention Agenda 2017 state targets for the indicators. Sub-indicators are included in these datasets to measure health disparities among socioeconomic groups. For more information, check out: http://www.health.ny.gov/prevention/prevention_agenda/2013-2017/ and https://www.health.ny.gov/PreventionAgendaDashboard. The "About" tab contains additional details concerning this dataset.

The graph shows the changes in the impact factor of ^ and its corresponding percentile for the sake of comparison with the entire literature. Impact Factor is the most common scientometric index, which is defined by the number of citations of papers in two preceding years divided by the number of papers published in those years.

Around ** percent of the global adult population suffered from diabetes in 2024 - by the year 2050 this number is expected to rise to ** percent. Diabetes, or diabetes mellitus, refers to a group of metabolic disorders that result in chronic high blood sugar levels. Diabetes can lead to serious health complications, such as cardiovascular disease, chronic kidney disease, and stroke, and is now among the top ten leading causes of death worldwide. Prevalence Diabetes is a global problem affecting many countries. China currently has the largest number of diabetics worldwide, with some *** million people suffering from the disease. However, the highest prevalence of diabetes is found in Pakistan, followed by the Marshall Islands and Kuwait. Rates of diabetes have increased in many countries in recent years, as have rates of obesity, one of the leading risk factors for the disease. Outlook It is predicted that diabetes will continue to be a problem in the future. Africa is expected to see a *** percent increase in the number of diabetics in the region from 2024 to 2050, while North America and the Caribbean are expected to see an increase of ** percent. In 2050, China is predicted to be the country with the highest number of diabetics worldwide, with the United States accounting for the fourth-highest number.

Global Hospital Average Length of Stay for Diabetes Cases by Country, 2023 Discover more data with ReportLinker!

Diabetic Food Market Outlook

According to our latest research, the global diabetic food market size reached USD 13.4 billion in 2024, reflecting robust consumer demand and increasing health awareness worldwide. The market is demonstrating a strong momentum with a recorded CAGR of 5.7% during 2024. This growth is primarily fueled by the rising prevalence of diabetes, shifting dietary patterns, and expanding product innovation. As per our projections, the market is expected to reach USD 21.2 billion by 2033, as manufacturers and retailers continue to cater to the evolving needs of diabetic consumers across the globe. The market's upward trajectory is underpinned by heightened health consciousness, government initiatives, and advances in food technology.

A significant growth factor for the diabetic food market is the alarming increase in diabetes prevalence worldwide. The International Diabetes Federation reports that over 537 million adults are living with diabetes globally, with numbers expected to rise in the coming years. This surge in diabetic cases has led to an amplified demand for specialized food products that help manage blood glucose levels without compromising taste or nutrition. Manufacturers are responding with innovative formulations, such as low-glycemic index ingredients and sugar substitutes, to make diabetic-friendly alternatives more accessible. Additionally, the growing awareness among consumers about the long-term health risks associated with high sugar intake has shifted preferences towards healthier food choices, further propelling market growth.

Technological advancements and product innovation are also playing a crucial role in driving the diabetic food market. Companies are investing heavily in research and development to create new product lines that cater to diabetic needs while maintaining flavor, texture, and nutritional value. The incorporation of natural sweeteners like stevia, monk fruit, and allulose is becoming increasingly common, replacing traditional sugars in bakery, confectionery, and beverage segments. Moreover, the rise of functional foods enriched with dietary fibers, proteins, and essential micronutrients is attracting health-conscious consumers, including those at risk of developing diabetes. This trend is further supported by strategic collaborations between food manufacturers and health organizations, emphasizing the importance of balanced diets for diabetes management.

Another key growth driver is the proactive role of governments and healthcare organizations in promoting diabetes awareness and healthy eating habits. Many countries have introduced regulations and guidelines to limit sugar consumption in processed foods, encouraging the food industry to reformulate their products. Public health campaigns and educational programs are also instrumental in informing consumers about the benefits of diabetic-friendly diets. In addition, the increasing availability of diabetic food products through diverse distribution channels, including online stores and specialty outlets, has made it easier for consumers to access these products. This multi-faceted approach, combining regulatory support, public awareness, and enhanced product availability, is expected to sustain the market's growth trajectory in the coming years.

In addition to food products, the diabetic market is witnessing a growing interest in Diabetic Drinks. These beverages are specifically formulated to help manage blood sugar levels while providing essential hydration and nutrients. With the increasing prevalence of diabetes, consumers are seeking alternatives to traditional sugary drinks, leading to innovations in sugar-free and low-glycemic beverages. Companies are introducing a variety of options, including herbal teas, fortified waters, and nutrient-rich smoothies, all designed to support a diabetic-friendly lifestyle. The focus is on natural ingredients and functional benefits, catering to the health-conscious consumer who prioritizes both taste and wellness. As the beverage segment continues to expand, it is expected to play a significant role in the overall growth of the diabetic food market.

From a regional perspective, North America continues to dominate the diabetic food market, driven by a high prevalence of diabetes, advanced healthcare infrastructure, and strong consumer purchasing power

The global diabetic test strip market is experiencing steady growth, projected to reach a market size of approximately $10 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 5% from 2025 to 2033. This growth is driven by several factors, including the rising prevalence of diabetes globally, an aging population in many developed countries increasing the diabetic population, and increased awareness of the importance of regular blood glucose monitoring among individuals with diabetes. Technological advancements leading to more accurate, convenient, and user-friendly test strips also contribute significantly to market expansion. The market is segmented by various factors such as technology type (e.g., electrochemical, photometric), application (e.g., self-monitoring, point-of-care testing), and end-user (e.g., hospitals, home use). This segmentation allows manufacturers to target specific customer needs and preferences, furthering market penetration. Competitive intensity within the market is high, with key players like Abbott, Bayer, Roche, LifeScan, and others vying for market share through product innovation, strategic partnerships, and expansion into emerging markets. However, the market also faces certain restraints, including price sensitivity among consumers, particularly in developing economies, and the potential for reimbursement challenges in healthcare systems. Furthermore, the emergence of continuous glucose monitoring (CGM) systems presents an alternative technology that is gradually competing with traditional test strips, requiring manufacturers to adapt and innovate to maintain market position. Despite these challenges, the long-term outlook for the diabetic test strip market remains positive, fueled by the persistently high and growing prevalence of diabetes worldwide.